ReviewDie Naturwissenschaften2026
Significance of secondary metabolites for synthesis of metal and metal oxide nanoparticles and their applications.
Review in Die Naturwissenschaften, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Secondary metabolites, produced by plants, fungi, and microorganisms, are a diverse group of bioactive compounds that play crucial roles in ecological interactions and defense mechanisms. In recent years, these metabolites have garnered significant attention as natural reducing, stabilizing, and capping agents in the green synthesis of metal and metal oxide nanoparticles (NPs). Phytochemicals such as flavonoids, alkaloids, terpenoids, saponins, tannins, and phenolic acids possess functional groups capable of mediating the reduction of metal ions to nanoscale forms while providing stability against aggregation. This eco-friendly synthesis approach offers several advantages over conventional physical and chemical methods, including reduced toxicity, lower energy requirements, and cost-effectiveness. The nature and concentration of secondary metabolites directly influence nanoparticle size, morphology, and functional properties, which in turn determine their potential applications. Metal and metal oxide nanoparticles synthesized using secondary metabolites have demonstrated broad-spectrum applications in antimicrobial, antioxidant, anticancer, and anti-inflammatory therapies, as well as in environmental remediation, biosensing, and catalysis, their biocompatibility and stability make them promising candidates for use in biomedical devices and agricultural formulations, the biochemical mechanisms by which secondary metabolites mediate nanoparticle synthesis, the factors influencing synthesis efficiency, and the diverse applications of such biologically derived nanomaterials. Emphasis is placed on the sustainable potential of leveraging plant- and microbe-derived metabolites for scalable nanoparticle production to meet global needs in medicine, agriculture, and environmental management.
Indexed as
Identifiers
42782294What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.